Test Summary

This immunoassay is for the detection of IgM and IgG antibodies against Sin Nombre virus (SNV), a New World Hantavirus species endemic in the United States. Laboratory testing can aid in the diagnosis of Hantavirus Pulmonary Syndrome (HPS) in a patient with consistent signs and symptoms of infection. 

HPS is caused primarily via inhalation of Hantavirus from contaminated rodent urine, droppings, or saliva. Symptoms may include fatigue, fever, muscle aches, with rapid progression to coughing and shortness of breath, which may be severe and life-threatening. Testing may be considered in patients with HPS-compatible symptoms who may have had contact with rodents or infested areas.

In addition to New World Hantavirus, there are Old World Hantaviruses (e.g. Seoul, Hantaan, Dobrava, and Puumala) endemic to Asia and Europe that cause hemorrhagic fever with renal syndrome, a condition not typically seen in the United States. This assay may or may not detect antibodies against these Old World Hantaviruses due to variable cross-reactivity with the target antigen. Negative antibody results may also occur early in infections, prior to seroconversion. Antibodies can be detected as early as the prodromal phase of infection (3-7 days). IgM results may be detected for months and IgG for up to several years after acute infection. Cross-reactivivty with autoimmune conditions can occur. Therefore, the results of this test should be interpreted in the context of pertinent clinical and physical findings.

Aliases

Specimen Collection

Special Instructions

Preferred Specimen

Minimum Volume

Instructions

Patient Preparation

Storage

Transport Temperature

Specimen Stability

Limitations

Other Acceptable Specimens

Unacceptable Specimens

Order Code

EPIC (Premier) Code

Includes

CPT Code

Billing Code

CPT Statement

Methodology

FDA Status

Physician Attestation of Informed Consent

Testing Laboratory

Department

Reference Range

Setup Schedule / Expected Turnaround Time